The global peptide synthesis sector is gaining momentum as demand for peptide-based medicines, advanced research tools, and diagnostic solutions continues to increase. It was valued at USD 774.06 million in 2025, reached USD 872.68 million in 2026, and is projected to reach USD 2,567.76 million by 2035, expanding at a CAGR of 12.74% from 2026 to 2035.
Key Trends
Peptide synthesis involves linking amino acids to create peptides that can be used in drug development, diagnostics, biomedical research, and other applications. Growing research into chronic diseases such as cancer, metabolic disorders, cardiovascular conditions, and infectious diseases is increasing the need for novel peptide-based solutions.
Advancements in synthesis technologies are also improving production efficiency and scalability. In September 2024, Snapdragon Chemistry developed a liquid-phase peptide synthesis technology designed to reduce solvent use and excess reagents compared with conventional solid-phase approaches.
Sustainability is becoming another important focus. In May 2024, Donaldson Company and PolyPeptide Group collaborated on a production-scale solvent recovery system for peptide purification, supporting more environmentally responsible manufacturing.
Impact of AI
Artificial intelligence and machine learning are creating new possibilities in peptide research. These technologies can help researchers predict peptide activity, evaluate protein-peptide interactions, identify promising candidates, and assess potential toxicity.
AI can also support automated synthesis and laboratory workflows. By combining predictive models with robotics and experimental data, researchers can screen larger numbers of peptide candidates while reducing manual work and improving efficiency.
Key Segment Insights
By product, reagents and consumables held the leading position in 2025 because amino acids, resins, coupling reagents, and other materials are essential for peptide production. The equipment segment is expected to grow rapidly as automated and advanced synthesis systems become more widely adopted.
By technology, liquid-phase peptide synthesis led in 2025, while hybrid technology is expected to expand at the fastest pace. Combining chemical and recombinant approaches can provide greater flexibility when producing complex peptides.
By application, therapeutics accounted for the largest share in 2025. Growing demand for peptide-based treatments in cancer, metabolic disorders, cardiovascular conditions, and other diseases is supporting this segment.
Regional Outlook
North America held the leading position in 2025, supported by advanced research facilities, pharmaceutical companies, biotechnology firms, and strong investment in peptide-based drug development.
Asia-Pacific is expected to experience notable growth as pharmaceutical and biotechnology capabilities expand across countries such as India and China. Government support, increasing investments, and technological adoption are further strengthening regional development.
Download a Sample Report: https://www.towardshealthcare.com/download-sample/5393
Future Outlook
The future of peptide synthesis will be shaped by AI-driven peptide design, hybrid synthesis technologies, automated equipment, recombinant production, sustainable manufacturing, and rising demand for peptide therapeutics. As researchers continue developing more complex and targeted peptides, synthesis technologies are expected to become faster, more efficient, scalable, and environmentally responsible.
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium